GridAI Technologies (GRDX) Assets (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Assets came in at $48.6 million in Q4 2025, down 43.15% YoY from $85.4 million in Q4 2024, and down 64.13% on a QoQ basis from $135.4 million in Q3 2025.
GridAI Technologies (GRDX) Assets (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Assets data on file, last reported at $48.6 million in Q4 2025.
- Quarterly Assets fell 43.15% year-over-year to $48.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $48.6 million (down 43.15% YoY) and the FY2025 annual result came in at $48.6 million, down 43.15% from the prior year.
- Assets eased to $48.6 million in Q4 2025, from $135.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $135.4 million in Q3 2025 to a low of $3.9 million in Q2 2022.
- A 5-year average of $40.2 million and a median of $13.1 million in 2021 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets sank 71.49% — and 2024, when it jumped 1893.76%.
- Tracing GRDX's Assets over 5 years: stood at $11.8 million in 2021, then plunged by 53.86% to $5.4 million in 2022, then increased by 26.54% to $6.9 million in 2023, then soared by 1140.84% to $85.4 million in 2024, then plunged by 43.15% to $48.6 million in 2025.
- The last three Assets figures came in at $48.6 million (Q4 2025), $135.4 million (Q3 2025), and $85.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | 48.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.55 Mn |
| Sep 30, 2025 | 135.37 Mn |
| Jun 30, 2025 | 85.06 Mn |
| Mar 31, 2025 | 85.20 Mn |
| Dec 31, 2024 | 85.41 Mn |
| Sep 30, 2024 | 85.82 Mn |
| Jun 30, 2024 | 86.29 Mn |
| Mar 31, 2024 | 91.13 Mn |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 5.93 Mn |
| Jun 30, 2023 | 4.33 Mn |
| Mar 31, 2023 | 5.53 Mn |
| Dec 31, 2022 | 5.44 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Jun 30, 2022 | 3.93 Mn |
| Mar 31, 2022 | 8.83 Mn |
| Dec 31, 2021 | 11.79 Mn |
| Sep 30, 2021 | 12.42 Mn |
| Jun 30, 2021 | 13.78 Mn |
| Mar 31, 2021 | 17.98 Mn |